Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin diseaseSphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healingThe use of reconstructed human epidermis for skin absorption testing: Results of the validation studyNanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles.3D-wound healing model: influence of morphine and solid lipid nanoparticles.Data-based modeling of drug penetration relates human skin barrier function to the interplay of diffusivity and free-energy profiles.Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation.Sphingosine-1-phosphate signaling and the skin.Influence of massage and occlusion on the ex vivo skin penetration of rigid liposomes and invasomes.Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling.A Highly Photostable Hyperbranched Polyglycerol-Based NIR Fluorescence Nanoplatform for Mitochondria-Specific Cell Imaging.Human defensins.Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?Biocompatibility and characterization of polyglycerol-based thermoresponsive nanogels designed as novel drug-delivery systems and their intracellular localization in keratinocytes.Receptor-selective retinoids for psoriasis: focus on tazarotene.Lipid nanoparticles for improved topical application of drugs for skin diseases.Carriers in the topical treatment of skin disease.In vitro models for human skin disease.Perspectives on percutaneous penetration: Silica nanoparticles.Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes.Dendritic nanoparticles for cutaneous drug delivery--testing in human skin and reconstructed human skin.Impact of structural differences in hyperbranched polyglycerol–polyethylene glycol nanoparticles on dermal drug delivery and biocompatibility.Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin.Cytoprotective effects of opioids on irradiated oral epithelial cells.Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate.Molecular modelling studies of new potential human DNA polymerase α inhibitors.Tailored dendritic core-multishell nanocarriers for efficient dermal drug delivery: A systematic top-down approach from synthesis to preclinical testing.Antitumor effects of guanosine-analog phosphonates identified by molecular modelling.Human polymerase alpha inhibitors for skin tumors. Part 2. Modeling, synthesis and influence on normal and transformed keratinocytes of new thymidine and purine derivatives.Evaluation of anti-inflammatory and atrophogenic effects of glucocorticoids on reconstructed human skin.Synergistic effects of dexamethasone and quinolones on human-derived tendon cells.Influences of opioids and nanoparticles on in vitro wound healing models.SV40-transformed human corneal keratocytes: optimisation of serum-free culture conditions.Characterisation of human corneal epithelial cell cultures maintained under serum-free conditions.Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake.Structural aspects of histone H1-DNA complexes and their relation to transfection efficiency.Integrin specificity of the cyclic Arg-Gly-Asp motif and its role in integrin-targeted gene transfer.TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts.Increased cutaneous absorption reflects impaired barrier function of reconstructed skin models mimicking keratinisation disorders.SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
P50
Q24294533-2F49169F-4775-4153-914D-A4CF7B5ACCD6Q28185201-6C03BA1C-AD27-467B-9371-A0F962AA2E04Q28282521-7B248A50-AC63-4256-B83E-9A589E724F22Q33370008-D70BA5AF-86BF-4665-8821-62E0D3E5BE75Q33530001-6AC28ACE-171A-404C-BE8D-7FE6571A9425Q33556888-3A9DC650-21EA-464D-822E-348AB8F691B2Q34382523-4BA27E0A-8CE7-4C8A-927F-BFB81AD7E93DQ34585376-1EDB386E-293B-46D4-AAB1-291D00463D30Q35047063-8B3A9EC4-B4FF-4417-BF49-1B826FFCF837Q35570447-26062900-B50F-4BF7-B468-CBA73A2B3828Q36038123-06A4E131-B998-4AC4-9AAB-E2E6E1C12152Q36094398-5D8812BD-BFB6-4DC9-BE4B-0809906CABFCQ36257125-21B1F012-E05D-477D-BF8E-BD0843A0A9F0Q36271453-25993213-EF1C-491E-AA1C-1DCEC4FE9363Q36444861-1EB45BC1-8592-4604-A038-A975C0518DE1Q36838029-80E284FD-8469-41B4-AE3A-A66CD08D5C45Q37706323-82E7BB36-7474-4FE6-A9C2-C701AFBCD289Q37819171-CBA0E3C4-B6A3-4003-8042-BBF6EAB719EEQ38257079-121A9EEA-9CBA-40DB-82C8-99A93CAC9CD1Q38339058-A5BF362E-E174-4FDD-8299-A5B6017C427DQ38449695-300F909B-3F11-4278-A55C-C6222B118841Q38935951-27A429A6-321E-409C-A9D4-E87AC79DCF9EQ39012520-F521C2E2-1B37-4E72-9F2D-FE22F38E5854Q39077533-A073097D-1D06-48E1-B2D7-6A752E5B2D15Q39234857-700DEA89-001F-4D0C-8AC2-A4F32AB32E9FQ39642339-AB0987CF-3AC5-4985-ADB5-7491ED45D173Q39651335-5FD86E85-039E-4BF9-9304-160E78FCA88EQ39684670-A8563D57-F345-4129-831D-348CDBC9F11EQ39728918-173B7D83-89C7-4C75-B36A-892E1D8915C1Q39742980-273C6C19-77DF-4F16-98CD-E53A74453B53Q39759079-EF1B5714-6A6C-4791-9FE5-88B8D0D8E73BQ39864291-97E89EB7-6318-4E42-A11F-D97416D8F184Q39867589-049A95C5-8995-47D7-A08E-FE49DA9968CCQ39913632-6393B7DB-6F93-40CD-BF99-63E14C13D222Q40156826-016CB4A8-8554-4431-9486-3741E4ACA591Q40449109-934E3D0E-5859-4ADD-884F-E64507AA2A53Q40583903-44A3255E-8929-4D53-B9CC-DF215B24D488Q42232339-DCB10A59-0ABE-45B9-8342-ECA9D8C45CDAQ42805584-87044142-F7FA-4C07-8186-0A75E9318D56Q43163169-104F0420-26FF-4FB6-B5FE-0ECAB7932B54
P50
subject
description
Duits toxicologe
@nl
German pharmacologist
@en
German pharmacologist
@en-ca
German pharmacologist
@en-gb
cógaseolaí Gearmánach
@ga
deutsche Pharmakologin
@de
farmacóloga alemana
@es
tysk professor
@da
tysk professor
@sv
عالمة صيدلية ألمانية
@ar
name
Monika Schäfer-Korting
@ast
Monika Schäfer-Korting
@ca
Monika Schäfer-Korting
@da
Monika Schäfer-Korting
@de
Monika Schäfer-Korting
@en
Monika Schäfer-Korting
@es
Monika Schäfer-Korting
@fr
Monika Schäfer-Korting
@nb
Monika Schäfer-Korting
@nds
Monika Schäfer-Korting
@nl
type
label
Monika Schäfer-Korting
@ast
Monika Schäfer-Korting
@ca
Monika Schäfer-Korting
@da
Monika Schäfer-Korting
@de
Monika Schäfer-Korting
@en
Monika Schäfer-Korting
@es
Monika Schäfer-Korting
@fr
Monika Schäfer-Korting
@nb
Monika Schäfer-Korting
@nds
Monika Schäfer-Korting
@nl
altLabel
Monika Schafer-Korting
@nl
Schäfer-Korting
@de
prefLabel
Monika Schäfer-Korting
@ast
Monika Schäfer-Korting
@ca
Monika Schäfer-Korting
@da
Monika Schäfer-Korting
@de
Monika Schäfer-Korting
@en
Monika Schäfer-Korting
@es
Monika Schäfer-Korting
@fr
Monika Schäfer-Korting
@nb
Monika Schäfer-Korting
@nds
Monika Schäfer-Korting
@nl
P106
P1006
P214
P227
P244
P269
P1006
P1280
P1412
P1559
Monika Schäfer-Korting
@de
P19
P21
P213
0000 0001 0980 4409
P214
P227
P244
P269
P31
P512
P569
1952-05-07T00:00:00Z